Invesco
TEVA icon

Invesco’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$60.3M Sell
3,600,044
-1,087,208
-23% -$18.2M 0.01% 987
2025
Q1
$72M Sell
4,687,252
-1,377,277
-23% -$21.2M 0.01% 900
2024
Q4
$134M Buy
6,064,529
+355,581
+6% +$7.84M 0.02% 724
2024
Q3
$103M Buy
5,708,948
+959,358
+20% +$17.3M 0.02% 789
2024
Q2
$77.2M Buy
4,749,590
+4,540,171
+2,168% +$73.8M 0.02% 854
2024
Q1
$2.95M Sell
209,419
-705
-0.3% -$9.95K ﹤0.01% 2495
2023
Q4
$2.19M Sell
210,124
-8,775
-4% -$91.6K ﹤0.01% 2575
2023
Q3
$2.23M Buy
218,899
+2,557
+1% +$26.1K ﹤0.01% 2552
2023
Q2
$1.63M Sell
216,342
-50,350
-19% -$379K ﹤0.01% 2695
2023
Q1
$2.36M Sell
266,692
-114,093
-30% -$1.01M ﹤0.01% 2567
2022
Q4
$3.47M Buy
380,785
+2,643
+0.7% +$24.1K ﹤0.01% 2411
2022
Q3
$3.05M Buy
378,142
+14,231
+4% +$115K ﹤0.01% 2451
2022
Q2
$2.74M Buy
363,911
+15,116
+4% +$114K ﹤0.01% 2565
2022
Q1
$3.27M Buy
348,795
+4,097
+1% +$38.5K ﹤0.01% 2570
2021
Q4
$2.76M Sell
344,698
-385,785
-53% -$3.09M ﹤0.01% 2660
2021
Q3
$7.12M Sell
730,483
-235,841
-24% -$2.3M ﹤0.01% 2197
2021
Q2
$9.57M Buy
966,324
+98,831
+11% +$979K ﹤0.01% 2080
2021
Q1
$10M Sell
867,493
-676,632
-44% -$7.81M ﹤0.01% 1947
2020
Q4
$14.9M Buy
1,544,125
+202,388
+15% +$1.95M ﹤0.01% 1589
2020
Q3
$12.1M Sell
1,341,737
-482,973
-26% -$4.35M ﹤0.01% 1559
2020
Q2
$22.5M Sell
1,824,710
-210,206
-10% -$2.59M 0.01% 1234
2020
Q1
$18.3M Buy
2,034,916
+1,594,441
+362% +$14.3M 0.01% 1240
2019
Q4
$4.32M Buy
440,475
+271,981
+161% +$2.67M ﹤0.01% 2243
2019
Q3
$1.16M Buy
168,494
+49,918
+42% +$343K ﹤0.01% 2894
2019
Q2
$1.09M Buy
118,576
+63,585
+116% +$587K ﹤0.01% 3001
2019
Q1
$862K Buy
54,991
+14,730
+37% +$231K ﹤0.01% 3075
2018
Q4
$621K Sell
40,261
-7,297
-15% -$113K ﹤0.01% 3165
2018
Q3
$1.02M Sell
47,558
-32,459
-41% -$699K ﹤0.01% 3107
2018
Q2
$1.95M Sell
80,017
-39,790
-33% -$967K ﹤0.01% 2777
2018
Q1
$2.05M Sell
119,807
-2,154,622
-95% -$36.8M ﹤0.01% 2571
2017
Q4
$43.1M Sell
2,274,429
-9,942,473
-81% -$188M 0.02% 839
2017
Q3
$215M Sell
12,216,902
-2,517,972
-17% -$44.3M 0.08% 283
2017
Q2
$489M Sell
14,734,874
-66,245
-0.4% -$2.2M 0.15% 148
2017
Q1
$475M Sell
14,801,119
-65,084
-0.4% -$2.09M 0.16% 143
2016
Q4
$539M Buy
14,866,203
+557,681
+4% +$20.2M 0.18% 118
2016
Q3
$658M Sell
14,308,522
-520,153
-4% -$23.9M 0.23% 88
2016
Q2
$745M Sell
14,828,675
-4,077,251
-22% -$205M 0.27% 73
2016
Q1
$1.01B Sell
18,905,926
-439,575
-2% -$23.5M 0.41% 36
2015
Q4
$1.27B Buy
19,345,501
+45,177
+0.2% +$2.97M 0.51% 25
2015
Q3
$1.09B Sell
19,300,324
-1,770,625
-8% -$100M 0.46% 30
2015
Q2
$1.25B Sell
21,070,949
-1,045,741
-5% -$61.8M 0.49% 27
2015
Q1
$1.38B Buy
22,116,690
+1,691,669
+8% +$105M 0.53% 24
2014
Q4
$1.17B Buy
20,425,021
+494,959
+2% +$28.5M 0.45% 30
2014
Q3
$1.07B Buy
19,930,062
+303,293
+2% +$16.3M 0.43% 30
2014
Q2
$1.03B Buy
19,626,769
+5,004,774
+34% +$262M 0.4% 34
2014
Q1
$773M Buy
14,621,995
+4,378,244
+43% +$231M 0.31% 53
2013
Q4
$411M Sell
10,243,751
-4,147,704
-29% -$166M 0.16% 128
2013
Q3
$544M Buy
14,391,455
+2,237,612
+18% +$84.5M 0.24% 83
2013
Q2
$476M Buy
+12,153,843
New +$476M 0.22% 94